Hidde Ploegh

58PUBLICATIONS
204CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)GlycoconjugatesProteomics and intermolecular interactions (excl. medical proteomics)Innate immunityBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Aug 20, 2026
Fc-engineering for improved cancer immunotherapy.

|Nov 03, 2025
A multivalent nanobody-drug conjugate to prevent and treat influenza virus infections.

Thibault J Harmand, Laura Pietrok, Helen Rich

|Jul 16, 2025
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy.

Xin Liu, Camille Le Gall, Ryan K Alexander

|May 02, 2025
Site-specific labeling uncovers differences in levels and distribution of B-cell receptors of different isotypes on primary B cells.

Djenet Bousbaine, Eugene M Obeng, Zeyang Li

|Apr 15, 2025
A nanobody that binds to the backside of the ubiquitin conjugating enzyme Ube2G2 differentially affects interactions with its partner E3 Ligases.

Pavana Suresh, Charlotte Wijne, Zhen-Yu J Sun

|Apr 07, 2025
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses.

Xin Liu, Thomas Balligand, Camille Le Gall

Pageof 10

Frequent Collaborators

6 joint publications

Thibault J Harmand

5 joint publications

Ross W Cheloha

5 joint publications

Novalia Pishesha

4 joint publications

Yuelong Wu